TrialOphthalmology. Retina2022

Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.

Jason Q Core et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.